Prestige BioPharma Limited (KRX:950210)
South Korea · Delayed Price · Currency is KRW 3,890.00
-130.00 (-3.23%)
Nov 2, 2026, 3:30 PM KST
Prestige BioPharma Cash Flow Statement
Financials in millions KRW. Fiscal year is July - June.
Millions KRW. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -91,499 | 22,297 | -32,921 | 17,569 | -211,450 |
Depreciation & Amortization | 32,757 | 21,801 | 16,267 | 11,650 | 3,867 |
Loss (Gain) From Sale of Assets | -6.37 | 6.7 | -89.4 | -55.17 | -266.37 |
Asset Writedown & Restructuring Costs | 28,527 | -59,462 | - | 15,114 | 72,607 |
Loss (Gain) From Sale of Investments | 277.2 | - | - | 693.39 | 18,966 |
Stock-Based Compensation | 917.63 | 470.11 | 52.41 | 1,943 | 3,774 |
Provision & Write-off of Bad Debts | - | - | -33.31 | -70,640 | - |
Other Operating Activities | -22,508 | -31,684 | -42,356 | -17,826 | 85,640 |
Change in Accounts Receivable | -3,540 | -228.75 | 674.94 | -1,050 | - |
Change in Inventory | -9,369 | -4,764 | 7,752 | -10,038 | -24,041 |
Change in Accounts Payable | -492.61 | 4,196 | 2,459 | -316.4 | 1,641 |
Change in Unearned Revenue | -141.98 | -310.36 | -5.21 | -660.52 | 564.62 |
Change in Other Net Operating Assets | 9,261 | -4,456 | 172.41 | -6,658 | 2,791 |
Operating Cash Flow | -55,818 | -52,135 | -48,027 | -60,274 | -45,907 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -5,972 | -40,742 | -20,063 | -48,363 | -56,429 |
Sale of Property, Plant & Equipment | 114.25 | 94.2 | 51.21 | 1,133 | 26,428 |
Divestitures | - | - | - | 40,039 | - |
Sale (Purchase) of Intangibles | -5,524 | -6,028 | -7,463 | -17,254 | -11,684 |
Investment in Securities | 54,810 | -53,291 | 159,987 | -133,827 | -25,239 |
Other Investing Activities | -1,420 | -1,840 | -46.85 | 9,662 | 12,555 |
Investing Cash Flow | 42,008 | -101,806 | 132,465 | -148,610 | -184,685 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Long-Term Debt Issued | 14,970 | 53,319 | - | 55,772 | - |
Long-Term Debt Repaid | -64,867 | -4,008 | -2,771 | -2,589 | -4,504 |
Net Debt Issued (Repaid) | -49,897 | 49,311 | -2,771 | 53,183 | -4,504 |
Issuance of Common Stock | - | 1,117 | 1,307 | - | - |
Other Financing Activities | -915.89 | -564.1 | - | - | - |
Financing Cash Flow | -50,813 | 49,864 | -1,464 | 53,183 | -4,504 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Foreign Exchange Rate Adjustments | 266.81 | 1,850 | 608.72 | 6,888 | -3,177 |
Miscellaneous Cash Flow Adjustments | 0 | - | -0 | 0 | 0 |
Net Cash Flow | -64,356 | -102,228 | 83,582 | -148,813 | -238,273 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -61,790 | -92,877 | -68,091 | -108,636 | -102,336 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -237.00% | -648.33% | -9881.47% | -67125.45% | - |
Free Cash Flow Per Share | -1028.19 | -1545.47 | -1135.49 | -1807.71 | -1702.88 |
Levered Free Cash Flow | -37,033 | -125,005 | -46,364 | -23,046 | -114,523 |
Unlevered Free Cash Flow | -32,706 | -120,239 | -41,736 | -22,451 | -114,511 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | 3,712 | 12,207 | 6,082 | 1,834 | 436.07 |
Cash Income Tax Paid | 79.98 | -37.32 | -179.73 | 796.41 | 591.82 |
Change in Working Capital | -4,282 | -5,563 | 11,053 | -18,723 | -19,044 |